Cardiac hypertrophy, especially of the left ventricle, was apparent after Ang II infusion, confirming the induction of cardiac pressure overload, but there was no significant difference in the change in heart or LV weight observed in response to Ang II treatment between RPL3L-deficient and control mice (Supplementary Fig. 3a). This evidence concerns the gene RPL3L and cardiac hypertrophy.